Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)
Clinical trial NCT01753570 · COMPLETED
Trial details
- NCT number
- NCT01753570
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2015-10-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.